Clinilabs Fireside Chat: Unlocking Earlier Detection in Alzheimer's disease

Bob Dagher, MD, Chief Medical Officer at Clinilabs, and Robin Wolz,PhD, Chief Scientific and Medical Officer at IXICO, as they discuss the latest innovations in neuroimaging, blood-based biomarkers, and multimodal approaches that are transforming Alzheimer's disease research. Learn how these emerging technologies are improving patient selection, enhancing safety and efficacy assessments, and helping to drive more precise and successful clinical trial outcomes.